All over the U.S., people taking PrEP are being urged to go with Descovy instead of Truvada. Our HIV prevention expert answers the question: Is it worthwhile to make the switch?
Ready, Set, PrEP expands access to pre-exposure prophylaxis meds, but it doesn't cover other costs.
"Let these names burn in your heart to fuel your desire to live."
As Gilead pressures health care providers to switch to the newer drug, here's some information to make sure you can make the best decision for your health.
While many celebrated the FDA approval of Descovy for PrEP earlier this month, advocates wonder whether it will make biomedical HIV prevention more or less accessible to those most in need.
Personal injury lawsuit ads targeting social media have become daily sightings. But are they doing more harm than good?
The PrEP Access and Coverage Act would guarantee insurance coverage for PrEP and fund PrEP for the uninsured.
Activists say this relatively small giveaway won't advance PrEP access or help end HIV in the U.S. the way a true price reduction would.
April 18, 2019: lamivudine/raltegravir for PrEP; feminizing hormone may impact PrEP efficacy; why TAF has a better renal profile than TDF; the role of internet dating in HIV incidence trends.
For LGBT Health Awareness Week, educator Tyunique Nelson argues that PrEP education and access for youth have to be a top priority.